CRM vendor invests in data sources to upgrade its offerings for life sciences regulatory and marketing operations
In acquiring the Irvine, CA-based database provider, Cegedim Dendrite (Bedminster, NJ) will expect right off to continue growing SK&A’s service for verifying contact information with 800,000 healthcare providers, and will integrate that information into the OneKey service, its existing database of providers. OneKey is used to locate healthcare providers in 80 nations. But down the road, according to Bill Buzzeo, manager of market access at Cegidim Dendrite, the SK&A database will be useful for solving another industry problem: identifying and tracking the ever-shifting professional affiliations of prescribers and other pharmaceutical purchasers. This will be useful both for managing aggregate spending reports (a growing requirement among states) and for addressing the nagging problems of resolving conflicting or erroneous information in business affiliations like group purchasing organizations (GPOs).
Dave Escalante, president of SK&A, notes that simply tracking where providers are and how they can be reached is no trivial task; “there’s a 15-18% turnover in contact information annually, and the process of tracking this across 800,000 providers is a challenge.” SK&A touts its process of contacting all providers by telephone at least twice a year, and over the past three years, the company has increased its pharma clients from two to 22.
Starting a year ago, SK&A began obtaining additional information on business and professional relationships among prescribers, such as the professional societies they belong to, or the GPO that their business office might use. This information, in turn, will become valuable for Cegedim-Dendrite offerings like State Guardian and Nucleus Pharma, that Buzzeo’s group manages. Those services are helpful for creating master data lists for managing aggregate spending, PDMA compliance and other marketing reporting requirements.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.